These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35219600)

  • 1. Do Medicine Shortages Reduce Access and Increase Pharmaceutical Expenditure? A Retrospective Analysis of Switzerland 2015-2020.
    Blankart KE; Felder S
    Value Health; 2022 Jul; 25(7):1124-1132. PubMed ID: 35219600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Shortages Prior to and During the COVID-19 Pandemic.
    Callaway Kim K; Rothenberger SD; Tadrous M; Hernandez I; Gellad WF; Devine JW; Hershey TB; Maillart LM; Suda KJ
    JAMA Netw Open; 2024 Apr; 7(4):e244246. PubMed ID: 38578641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with drug shortages in Canada: a retrospective cohort study.
    Zhang W; Guh DP; Sun H; Lynd LD; Hollis A; Grootendorst P; Anis AH
    CMAJ Open; 2020; 8(3):E535-E544. PubMed ID: 32873582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of drug shortages on drug prices: evidence from China.
    Hu S; Zhang J; Li J; Zhang J; Pan M; Xiang C; Dave CV; Yang C; Fang Y
    Front Public Health; 2023; 11():1185356. PubMed ID: 38026336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies.
    Romano S; Galante H; Figueira D; Mendes Z; Rodrigues AT
    Res Social Adm Pharm; 2021 Jan; 17(1):1876-1881. PubMed ID: 32482587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicine shortages: Product life cycle phases and characteristics of medicines in short supply-A register study.
    Sarnola K; Kari H; Koskinen H
    Front Pharmacol; 2022; 13():943249. PubMed ID: 35833029
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of the COVID-19 Pandemic on Medical Product Procurement, Prices, and Supply Chain in Zimbabwe: Lessons for Supply Chain Resiliency.
    Yemeke TT; Umaru FA; Ferrand RA; Ozawa S
    Glob Health Sci Pract; 2023 Oct; 11(5):. PubMed ID: 37903588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA.
    Ravela R; Lyles A; Airaksinen M
    BMC Health Serv Res; 2022 Jul; 22(1):940. PubMed ID: 35869486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Medicine Shortages With the Twitter Social Network: Retrospective Observational Study.
    Postma DJ; Heijkoop MLA; De Smet PAGM; Notenboom K; Leufkens HGM; Mantel-Teeuwisse AK
    J Med Internet Res; 2024 Aug; 26():e51317. PubMed ID: 39106483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic: A Global Time Series Study.
    Callaway Kim K; Tadrous M; Kane-Gill SL; Barbash IJ; Rothenberger SD; Suda KJ
    Chest; 2021 Dec; 160(6):2123-2134. PubMed ID: 34389295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tackling medicine shortages during and after the COVID-19 pandemic: Compilation of governmental policy measures and developments in 38 countries.
    Vogler S
    Health Policy; 2024 May; 143():105030. PubMed ID: 38484475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
    Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers.
    Atif M; Malik I; Mushtaq I; Asghar S
    BMJ Open; 2019 Sep; 9(9):e027028. PubMed ID: 31488466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal for Handling of Medicine Shortages Based on a Comparison of Retrospective Risk Analysis.
    Turbucz B; Major M; Zelko R; Hanko B
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to address medicines shortages: Findings from a cross-sectional study of 24 countries.
    Vogler S; Fischer S
    Health Policy; 2020 Dec; 124(12):1287-1296. PubMed ID: 33032846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study.
    Dave CV; Pawar A; Fox ER; Brill G; Kesselheim AS
    Value Health; 2018 Nov; 21(11):1286-1290. PubMed ID: 30442275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case.
    Prada SI; Soto VE; Andia TS; Vaca CP; Morales ÁA; Márquez SR; Gaviria A
    Cost Eff Resour Alloc; 2018; 16():8. PubMed ID: 29507533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local causes of essential medicines shortages from the perspective of supply chain professionals in Saudi Arabia.
    AlRuthia Y; Mohammed Almutiri N; Musa Almutairi R; Almohammed O; Alhamdan H; Ali El-Haddad S; Abdu Asiri Y
    Saudi Pharm J; 2023 Jun; 31(6):948-954. PubMed ID: 37234344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug supply and assurance: a cross-sectional study of drug shortage monitoring varieties in China.
    Lan Y; Lin X; Chen Q; Wang L; Sun L; Huang Z
    BMC Public Health; 2024 Jul; 24(1):2048. PubMed ID: 39080661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating The Effects Of COVID-19 On Globalized Markets For Active Pharmaceutical Ingredients.
    Barber M; Ramachandran R; Moon S
    Health Aff (Millwood); 2024 Jul; 43(7):959-969. PubMed ID: 38950300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.